# Effects of Iloprost on Oxygenation During One-lung Ventilation in Supine-positioned Patients

> **NCT04927039** · NA · UNKNOWN · sponsor: **Yonsei University** · enrollment: 60 (estimated)

## Conditions studied

- Mediastinal Mass

## Interventions

- **DRUG:** 5ml of inhaled normal saline
- **DRUG:** 20μg (2ml) of inhaled iloprost (Ventavis®) and 3ml of inhaled normal saline

## Key facts

- **NCT ID:** NCT04927039
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-24
- **Primary completion:** 2023-06
- **Final completion:** 2023-06
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-06-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04927039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04927039, "Effects of Iloprost on Oxygenation During One-lung Ventilation in Supine-positioned Patients". Retrieved via MORVS 2026-09-29 from https://api.morvs.ai/clinical/NCT04927039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*